Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History $131.64 -2.02 (-1.51%) Closing price 04:00 PM EasternExtended Trading$131.32 -0.31 (-0.24%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Neurocrine Biosciences Stock Price Performance The Neurocrine Biosciences (NBIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 9.76%, with a year-to-date return of -3.56%. In the past month, the stock has increased 2.70%, reflecting recent market activity. As of the latest close, Neurocrine Biosciences traded at $133.66 with a market cap of $13.23 billion and volume of 773,184 shares. Five years ago, the stock traded at $125.20, representing a 5.14% increase over that period. At the time, it had a market cap of $11.67 billion and a volume of 478,212 shares. Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.29%1 Month Performance+2.70%3 Month Performance+24.47%Year-To-Date Performance-3.56%1 Year Performance-9.76%5 Year Performance+5.14% NBIX Stock Chart for Thursday, July, 24, 2025 NBIX Chart by TradingView Neurocrine Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$133.66$131.64-1.51%$135.00$131.43885,761 shs$13.03 billion07/23/2025$132.75$133.66+0.69%$134.32$132.10773,184 shs$13.23 billion07/22/2025$131.83$132.75+0.70%$133.32$132.22575,505 shs$13.14 billion07/21/2025$132.02$131.83-0.14%$133.80$131.51470,113 shs$13.05 billion07/18/2025$134.11$132.02-1.56%$134.94$131.12757,716 shs$13.07 billion07/17/2025$133.48$134.11+0.47%$135.70$131.88674,476 shs$13.27 billion07/16/2025$131.24$133.48+1.71%$134.25$131.07905,536 shs$13.21 billion07/15/2025$135.13$131.24-2.88%$136.25$131.13629,496 shs$12.99 billion07/14/2025$133.46$135.13+1.25%$135.45$131.75613,126 shs$13.37 billion07/11/2025$134.92$133.46-1.08%$135.00$132.10724,778 shs$13.21 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$133.51$134.92+1.06%$135.94$132.741.05 million shs$13.35 billion07/09/2025$128.74$133.51+3.71%$133.69$128.941.26 million shs$13.21 billion07/08/2025$127.88$128.74+0.67%$129.78$127.73753,911 shs$12.74 billion07/07/2025$128.04$127.88-0.12%$129.07$127.03537,941 shs$12.66 billion07/04/2025$128.04$128.04$131.00$128.47387,387 shs$12.67 billion07/03/2025$129.40$128.04-1.05%$131.00$128.47387,387 shs$12.67 billion07/02/2025$128.00$129.40+1.09%$130.42$127.521.19 million shs$12.81 billion07/01/2025$125.69$128.00+1.84%$129.27$126.15924,723 shs$12.67 billion06/30/2025$125.42$125.69+0.22%$127.36$125.42679,416 shs$12.44 billion06/27/2025$126.71$125.42-1.02%$127.26$125.021.26 million shs$12.41 billion06/26/2025$127.78$126.71-0.84%$128.66$126.20476,363 shs$12.54 billion06/25/2025$128.18$127.78-0.31%$128.61$126.61576,123 shs$12.65 billion06/24/2025$125.80$128.18+1.89%$128.50$123.04803,243 shs$12.69 billion06/23/2025$126.55$125.80-0.59%$127.99$125.061.06 million shs$12.45 billion Related Companies Alnylam Pharmaceuticals Stock Chart Biogen Stock Chart United Therapeutics Stock Chart Incyte Stock Chart Exelixis Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Madrigal Pharmaceuticals Stock Chart Halozyme Therapeutics Stock Chart Ionis Pharmaceuticals Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBIX Stock Alerts